\-\ Texto\\:\\ \ \(0\)\
\-\ diffusely\\ decreased\\ breath\\ sounds\\ with\\ dry\\ crackles\\ and\\ a\\ restrictive\\ pattern\\ on\\ pulmonary\\ function\\ tests\\.\ \(0\)\
\-\ diffuse\\ pulmonary\\ fibrosis\\ primarily\\ affecting\\ the\\ upper\\ lung\\ zones\\.\ \(1\)\
\-\ stage\\ iv\\ sarcoidosis\ \(0\)\
\-\ although\\ there\\ are\\ over\\ 140\\ known\\ causes\\ of\\ pulmonary\\ fibrosis\\ some\\ of\\ the\\ most\\ common\\ are\\:\\ \ \(0\)\
\-\ pneumoconioses\ \(2\)\
\-\ systemic\\ lupus\\ erythematosis\ \(0\)\
\-\ rheumatoid\\ arthritis\ \(67\)\
\-\ sarcoidosis\ \(108\)\
\-\ tuberculosis\ \(73\)\
\-\ medications\\ \\(nitrofurantoin\\,\\ amiodarone\\,\\ cyclophosphamide\\,\\ methotrexate\\,\\ bleomycin\\)\ \(0\)\
\-\ idiopathic\ \(111\)\
\-\ the\\ patient\\ presented\\ with\\ worsening\\ shortness\\ of\\ breath\\ and\\ dyspnea\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.25502812122945334\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.23627369438918033\ \(0\)\
\-\ fibrosis\\:\\ 0\\.23366523103981904\ \(0\)\
\-\ erythematosis\\:\\ 0\\.2230323431269246\ \(0\)\
\-\ nitrofurantoin\\:\\ 0\\.2060859022489114\ \(0\)\
\-\ breath\\:\\ 0\\.2044327399552861\ \(0\)\
\-\ bleomycin\\:\\ 0\\.19617286981458557\ \(0\)\
\-\ pneumoconioses\\:\\ 0\\.19240410979468925\ \(0\)\
\-\ restrictive\\:\\ 0\\.18135373060817134\ \(0\)\
\-\ amiodarone\\:\\ 0\\.18135373060817134\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.17377089350959224\ \(0\)\
\-\ zones\\:\\ 0\\.1644072897301581\ \(0\)\
\-\ methotrexate\\:\\ 0\\.15682445263157901\ \(0\)\
\-\ 140\\:\\ 0\\.1530556926116827\ \(0\)\
\-\ dry\\:\\ 0\\.14691142019725317\ \(0\)\
\-\ lupus\\:\\ 0\\.14533354718054592\ \(0\)\
\-\ crackles\\:\\ 0\\.143851363312274\ \(0\)\
\-\ affecting\\:\\ 0\\.140288921362472\ \(0\)\
\-\ primarily\\:\\ 0\\.13377905639792273\ \(0\)\
\-\ tests\\:\\ 0\\.13346358690845567\ \(0\)\
\-\ diffusely\\:\\ 0\\.12969482688855935\ \(0\)\
\-\ systemic\\:\\ 0\\.1237604145284702\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.12293157087555259\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.1227286772114048\ \(0\)\
\-\ dyspnea\\:\\ 0\\.1227286772114048\ \(0\)\
\-\ idiopathic\\:\\ 0\\.1179699622721016\ \(0\)\
\-\ medications\\:\\ 0\\.11699188999993493\ \(0\)\
\-\ arthritis\\:\\ 0\\.11342944805013296\ \(0\)\
\-\ function\\:\\ 0\\.11288308908527173\ \(0\)\
\-\ shortness\\:\\ 0\\.1118256898576721\ \(0\)\
\-\ stage\\:\\ 0\\.11106161060346233\ \(0\)\
\-\ sounds\\:\\ 0\\.10767190540462317\ \(0\)\
\-\ worsening\\:\\ 0\\.10649985524530488\ \(0\)\
\-\ are\\:\\ 0\\.1058400375789585\ \(0\)\
\-\ causes\\:\\ 0\\.10538143151744403\ \(0\)\
\-\ pattern\\:\\ 0\\.10412241632729129\ \(0\)\
\-\ iv\\:\\ 0\\.09964919172453963\ \(0\)\
\-\ although\\:\\ 0\\.09494401337836673\ \(0\)\
\-\ known\\:\\ 0\\.09029273559790173\ \(0\)\
\-\ some\\:\\ 0\\.08774901448380812\ \(0\)\
\-\ diffuse\\:\\ 0\\.0874608161028189\ \(0\)\
\-\ decreased\\:\\ 0\\.08638649510580634\ \(0\)\
\-\ lung\\:\\ 0\\.08483720017092161\ \(0\)\
\-\ the\\:\\ 0\\.08348400709805368\ \(0\)\
\-\ of\\:\\ 0\\.0818771121864892\ \(0\)\
\-\ presented\\:\\ 0\\.08132715734004964\ \(0\)\
\-\ common\\:\\ 0\\.07909172392997464\ \(0\)\
\-\ over\\:\\ 0\\.07754778366849306\ \(0\)\
\-\ upper\\:\\ 0\\.07452708285123012\ \(0\)\
\-\ most\\:\\ 0\\.0725809782223792\ \(0\)\
\-\ and\\:\\ 0\\.05763680969007082\ \(0\)\
\-\ there\\:\\ 0\\.055492055347262134\ \(0\)\
\-\ with\\:\\ 0\\.05461735582767359\ \(0\)\
\-\ patient\\:\\ 0\\.045360443867931456\ \(0\)\
\-\ on\\:\\ 0\\.042120341643594295\ \(0\)\
